Related Experiment Videos
Kynurenine metabolism in multiple sclerosis.
Z Hartai1, P Klivenyi, T Janaky
1Department of Neurology, University of Szeged, Szeged, Hungary.
Acta Neurologica Scandinavica
|July 13, 2005
Summary
The kynurenine system, involving kynurenic acid and quinolinic acid, is implicated in multiple sclerosis (MS). Enzyme activities and kynurenic acid levels are altered in MS patients, suggesting a potential protective mechanism and new therapeutic targets.
Area of Science:
- Neuroscience
- Biochemistry
- Immunology
Background:
- Excitatory amino acid receptors are crucial in brain function and implicated in neurological disorders.
- Multiple sclerosis (MS) pathogenesis may involve these receptors, with previous studies showing symptom improvement upon receptor blockade.
- Decreased kynurenic acid levels were observed in the cerebrospinal fluid of MS patients.
Purpose of the Study:
- To investigate the role of the kynurenine system in multiple sclerosis (MS).
- To measure kynurenine aminotransferase (KAT) enzyme activities and kynurenic acid concentrations in MS patients.
- To explore potential compensatory mechanisms in MS pathogenesis.
Main Methods:
- Assessed kynurenine aminotransferase I (KAT I) and KAT II activities in red blood cells (RBC) and plasma.
- Measured kynurenic acid concentration in RBC and plasma of MS patients and control subjects.
Main Results:
- KAT I and KAT II activities were significantly higher in the RBC of MS patients compared to controls.
- Kynurenic acid concentration was elevated in the plasma of MS patients.
- A trend towards elevated kynurenic acid was observed in the RBC of MS patients.
Conclusions:
- The kynurenine system is involved in the pathogenesis of multiple sclerosis (MS).
- Elevated KAT activities and kynurenic acid levels may represent a compensatory protective mechanism against excitotoxicity in MS.
- These findings suggest novel therapeutic strategies targeting the kynurenine system for MS treatment.